No FDA-Approved IL-15 Drug for Cancer Prevention Exists
There is currently no FDA-approved drug containing interleukin-15 (IL-15) specifically for cancer prevention. IL-15-based therapies are being developed and tested exclusively for cancer treatment, not prevention.
Current Status of IL-15 in Cancer Therapy
FDA-Approved IL-15 Therapy
- Nogapendekin alfa inbakicept (N-803) is the only FDA-approved IL-15-based immunotherapy, but it is indicated for treating existing cancer, not preventing it 1.
Clinical Development Focus
IL-15 therapies are being investigated in multiple clinical trials for cancer treatment in patients with established malignancies:
- Recombinant human IL-15 (rhIL-15) has been tested in patients with metastatic melanoma and renal cell cancer, showing immune activation but requiring dose optimization due to toxicities including hypotension, thrombocytopenia, and liver enzyme elevations 2
- Combination trials are ongoing with checkpoint inhibitors (IL-15 + nivolumab + ipilimumab, NCT03388632), monoclonal antibodies (IL-15 + alemtuzumab for ATL, NCT02689453; IL-15 + obinutuzumab for CLL, NCT03759184), and other immunotherapies 3
Why IL-15 Is Not Used for Prevention
IL-15 is a potent immunostimulatory cytokine that causes:
- Massive expansion of NK cells (up to 50-fold) and CD8+ T cells 2
- Significant inflammatory cytokine release (up to 50-fold increases in serum inflammatory markers) 2
- Dose-limiting toxicities even at therapeutic doses 2
These properties make IL-15 unsuitable for cancer prevention in healthy individuals, where the risk-benefit ratio would be unacceptable.
Important Distinction: Treatment vs. Prevention
The evidence consistently shows IL-15 is being developed as:
- Therapeutic agent for patients with active cancer 3, 2, 1
- Adjunct to other cancer treatments like checkpoint inhibitors and CAR-T cells 1
- Component of tumor-infiltrating lymphocyte (TIL) therapy where it supports immune cell expansion after tumor resection 4
No clinical trials or regulatory pathways exist for IL-15 as a cancer prevention agent in healthy populations.